Circulating Soluble Urokinase-Type Plasminogen Activator Receptor Levels Reflect Renal Function in Newly Diagnosed Patients with Multiple Myeloma Treated with Bortezomib-Based Induction

(1) Background: Soluble urokinase-type plasminogen activator receptor (suPAR) has been implicated in the pathogenesis of kidney disease in different disease settings. The aim of this study was to investigate a possible link between suPAR circulating levels and renal impairment (RI) in newly diagnose...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Clin Med
Autori principali: Terpos, Evangelos, Ntanasis-Stathopoulos, Ioannis, Papassotiriou, Gerasimos-Petros, Kastritis, Efstathios, Margeli, Alexandra, Kanellias, Nikolaos, Eleutherakis-Papaiakovou, Evangelos, Migkou, Magdalini, Fotiou, Despina, Roussou, Maria, Gavriatopoulou, Maria, Malandrakis, Panagiotis, Psimenou, Erasmia, Papassotiriou, Ioannis, Dimopoulos, Meletios A.
Natura: Artigo
Lingua:Inglês
Pubblicazione: MDPI 2020
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7600599/
https://ncbi.nlm.nih.gov/pubmed/33022958
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm9103201
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi